Literature DB >> 11053219

Effects of a selective 5-HT(1B/1D) receptor agonist on spinal and trigeminal reflexes in the anaesthetized rabbit.

S Jenkins1, B Richardson, R W Clarke.   

Abstract

The effects of the 5-HT(1B/1D) receptor agonist L-741,604 on a trigeminally-mediated (jaw depressor) reflex and a spinally-mediated (flexion withdrawal) reflex have been compared between spinalized and intact, anaesthetized rabbits. L-741,604 depressed the jaw depressor reflex dose-dependently in all animals, to a median of 5% (inter-quartile range, IQR, 3 - 28%, n=18) of pre-drug levels after a cumulative dose of 3.1 micromol kg(-1) i.v. This effect was reversed by the 5-HT(1B/1D) antagonist GR 127,935 (1 - 2 micromol kg(-1) i.v.). The flexion withdrawal reflex was depressed by L-741, 604 in non-spinalized animals, to a median of 22% (IQR 10 - 36%, n=10) of pre-drug levels after the highest dose, an action that was reversed by GR 127,935. In spinalized rabbits, L-741,604 up to 0.3 micromol kg(-1) i.v. cumulative increased the flexion reflex to a median of 189% (IQR 169 - 198%, n=8) of pre-drug controls. With higher doses the reflex decreased, so that after 3.1 micromol kg(-1) it was 75% (IQR 55 - 96%) of pre-drug levels. Subsequent GR 127,935 increased reflexes to a median of 180% (IQR 136 - 219%) of controls. L-741,604 increased arterial blood pressure and decreased heart rate in both preparations, effects that were reversed by GR 127,935. Thus, when the spinal cord was intact L-741,604 inhibited spinal and trigeminal reflexes in the same way. Although spinalization enabled a non-5-HT(1B/1D)-mediated excitatory effect of L-741,604 on spinal reflexes, there was a clear inhibitory effect of the drug at high doses. These data suggest that L-741,604 inhibits spinal reflexes by increasing descending inhibition and by a direct action in the cord. The same processes could apply to inhibition of trigeminally-mediated events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053219      PMCID: PMC1572409          DOI: 10.1038/sj.bjp.0703649

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  The pathophysiology of migraine: a tentative synthesis.

Authors:  J W Lance
Journal:  Pathol Biol (Paris)       Date:  1992-04

2.  Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.

Authors:  K L Hoskin; H Kaube; P J Goadsby
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

3.  Rizatriptan has central antinociceptive effects against durally evoked responses.

Authors:  M J Cumberbatch; R G Hill; R J Hargreaves
Journal:  Eur J Pharmacol       Date:  1997-06-05       Impact factor: 4.432

4.  Sumatriptan and episodic pain syndromes other than migraine.

Authors:  Ian Roberts-Thomson; John Argyrides; Peter Pannall; Derek Frewin
Journal:  Pain       Date:  1996-09       Impact factor: 6.961

5.  Naratriptan: biological profile in animal models relevant to migraine.

Authors:  H E Connor; W Feniuk; D T Beattie; P C North; A W Oxford; D A Saynor; P P Humphrey
Journal:  Cephalalgia       Date:  1997-05       Impact factor: 6.292

6.  Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

Authors:  R J Storer; P J Goadsby
Journal:  Brain       Date:  1997-12       Impact factor: 13.501

7.  Positron emission tomography studies in headache.

Authors:  H C Diener
Journal:  Headache       Date:  1997 Nov-Dec       Impact factor: 5.887

8.  Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

Authors:  P J Goadsby; K L Hoskin
Journal:  Pain       Date:  1996-10       Impact factor: 6.961

9.  A dual effect of 5-HT1B receptor stimulation on nociceptive dorsal horn neurones in rats.

Authors:  J Gjerstad; A Tjølsen; K Hole
Journal:  Eur J Pharmacol       Date:  1997-09-24       Impact factor: 4.432

10.  Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.

Authors:  P J Goadsby; L Edvinsson
Journal:  Headache       Date:  1994 Jul-Aug       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.